< Back to previous page
Researcher
Steven Simoens
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Jul 2013 → Today
Projects
11 - 20 of 22
- How to reimburse and pay orphan drugs for rare diseases?From1 Jan 2019 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
- Health-economic evaluations of prevention policies in FlandersFrom1 May 2017 → 18 Jan 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Patient Preferences in Drug Development and Evaluation: Issues and RecommendationsFrom3 Oct 2016 → 20 Oct 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- PAVING the way: Patient preferences to Assess Value IN Gene therapiesFrom29 Sep 2016 → 9 Oct 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Sustainable biosimilar competition: clinical, regulatory and policy insightsFrom20 Sep 2016 → 18 Nov 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Value and Market Access of Complementary DiagnosticsFrom7 Sep 2016 → 28 Jun 2022Funding: FWO Strategic Basic Research Grant, Private funding of national origin - undefined
- Assessment of market access policies and instruments for oncology drugs.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
- Rare diseases and orphan drugs: patient values, market trends and misconceptions.From1 Oct 2013 → 11 Jan 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
- Economic Evaluations of Welfare Interventions: from Hurdles to ImplementationFrom5 Nov 2012 → 7 Dec 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
- Analysis of policies regarding market access of oncology drugs.From1 Sep 2012 → 31 Dec 2017Funding: IWT personal funding - strategic basic research grants, BOF - Doctoral projects
Publications
1 - 10 of 428
- Drug pricing and transparency in Europe and the United States: what is it and how does it work?(2024)
Authors: Steven Simoens
- An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators.(2024)
Authors: Walter Van Dyck, Steven Simoens
Pages: 21 - 34 - Cost-Utility of an Exercise Referral Scheme Versus Doing Nothing in Flemish Adults: Exploring the Impact of Key Assumptions(2024)
Authors: Steven Simoens
- Unlocking Biosimilar Benefits: An Exploration of Barriers to Biosimilar Adoption, Value Assessment and Market Sustainability(2023)
Authors: Teresa Barcina Lacosta, Steven Simoens, Isabelle Huys
- Reply to Standaert, B. Comment on "Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium"(2023)
Authors: Steven Simoens
- Not one, but many: developing a multi-indication pricing model for medicines in Belgium(2023)
Authors: Steven Simoens
- A Belgian policy framework for best-value biological medicines(2023)
Authors: Yannick Vandenplas, Isabelle Huys, Steven Simoens, Arnold Vulto
- An international comparative analysis and roadmap to sustainable biosimilar markets(2023)
Authors: Steven Simoens
- A Systematic Literature Review of Gaps and Challenges in Value Assessment of Biosimilars: An ISPOR Special Interest Group Report(2023)
Authors: Steven Simoens
Pages: 1137 - 1144 - The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysis(2023)
Authors: Yannick Vandenplas, Steven Simoens, Arnold Vulto, Isabelle Huys